The Prescription of Oral Mucosal Mesenchymal Stem Cells post-Traumatic Brain Injury Improved the Kidney and Heart Inflammation and Oxidative Stress.
Maryam Radavi-AsgarNazanin SabetMohammad KhaksariElham JafariZahra SoltaniFatemeh DehghanianPublished in: BioMed research international (2022)
Application of OMSCs after TBI can decrease inflammation and oxidative stress of the heart and kidney tissues leading to the reduction of damage. Therefore, this method can be evaluated in the TBI patients in future studies.
Keyphrases
- oxidative stress
- traumatic brain injury
- mesenchymal stem cells
- diabetic rats
- dna damage
- ischemia reperfusion injury
- end stage renal disease
- induced apoptosis
- heart failure
- severe traumatic brain injury
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- atrial fibrillation
- stem cells
- umbilical cord
- patient reported outcomes
- mild traumatic brain injury
- endoplasmic reticulum stress
- patient reported